To fight Zika, FDA approves gene-altered mosquitoes

A female Aedes aegypti mosquito, known to be a carrier of the Zika virus. A promising new approach to fighting the Zika virus through the release of genetically modified mosquitoes won preliminary approval from the Food and Drug Administration Friday. After reviewing thousands of public comments over the last five months, the FDA concluded there would be “no significant impact” to human health or the environment from the program.